{"title":"FEATURES OF SENSITIZATION IN PATIENTS WITH ALOPECIA AREATA, ASSOCIATED WITH ATOPIC DISEASES","authors":"G. Tereshchenko","doi":"10.36691/rja16904","DOIUrl":null,"url":null,"abstract":"BACKGROUND: Association of alopecia areata (AA) and atopic diseases (AD) has been confirmed in clinical, epidemiologic, genetic and immunologic studies. The study of sensitization and AD structure in AA-patients makes it possible to develop atopy screening and suggest additional treatment options for AA. \nAIMS: To determine the sensitization spectrum and AD structure in patients with AA considering the age and clinical form of alopecia. \nMATERIALS AND METHODS: A comparative uncontrolled study was conducted. The data of 162 patients 5 - 51 years with AA, atopic dermatitis, asthma, allergic rhinitis/rhinoconjuctivitis for the period from April 2022 to May 2023 were used. The nature of sensitization and the structure of AD were analyzed. Clinical forms of AA were assessed by the hair-loss area. \nRESULTS: The patients were divided according to AA-status: the first group included 54 AA-patients with AD, the second (comparison group) - 108 atopic patients without AA. Subgroups were formed according to age: in group 1 - 31 (57%) were children (5 - 17 y.o.), 23 (43%) - adults 18 years and older; in group 2 – 58 (54%) and 50 (46%) children and adults, respectively. \nAmong AA-patients seasonal pollen sensitization prevailed (22/54 people); polyvalent sensitization was observed in 13/54 people, 6 of whom had severe forms of AA, 6 - ophiasis. Comparison of the sensitization spectrum between the groups revealed no differences. In group of adult AA-patients isolated respiratory allergies were significantly less frequent (OR 0.21; CI [0.07- 0.60], p=0.004), but combined AD were more frequently observed (OR 4.71; CI [1.43-15.58], p=0.012). Most patients with severe AA were children (8/12) with polyvalent sensitization and respiratory and combined AD. \nCONCLUSIONS: The comorbidity of AA and atopy is manifested by an increased incidence of severe alopecia in childhood and a tendency to progression of allergic inflammation, realized in the form of combined AD. The spectrum of sensitization in patients with and without AA does not differ and characterized by the predominance of the most common allergens (plant pollen). These results indicate the need for timely atopy detection and desensitization therapy in AA-patients, especially with early onset and active disease.","PeriodicalId":270411,"journal":{"name":"Russian Journal of Allergy","volume":"72 6","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-05-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Russian Journal of Allergy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.36691/rja16904","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
BACKGROUND: Association of alopecia areata (AA) and atopic diseases (AD) has been confirmed in clinical, epidemiologic, genetic and immunologic studies. The study of sensitization and AD structure in AA-patients makes it possible to develop atopy screening and suggest additional treatment options for AA.
AIMS: To determine the sensitization spectrum and AD structure in patients with AA considering the age and clinical form of alopecia.
MATERIALS AND METHODS: A comparative uncontrolled study was conducted. The data of 162 patients 5 - 51 years with AA, atopic dermatitis, asthma, allergic rhinitis/rhinoconjuctivitis for the period from April 2022 to May 2023 were used. The nature of sensitization and the structure of AD were analyzed. Clinical forms of AA were assessed by the hair-loss area.
RESULTS: The patients were divided according to AA-status: the first group included 54 AA-patients with AD, the second (comparison group) - 108 atopic patients without AA. Subgroups were formed according to age: in group 1 - 31 (57%) were children (5 - 17 y.o.), 23 (43%) - adults 18 years and older; in group 2 – 58 (54%) and 50 (46%) children and adults, respectively.
Among AA-patients seasonal pollen sensitization prevailed (22/54 people); polyvalent sensitization was observed in 13/54 people, 6 of whom had severe forms of AA, 6 - ophiasis. Comparison of the sensitization spectrum between the groups revealed no differences. In group of adult AA-patients isolated respiratory allergies were significantly less frequent (OR 0.21; CI [0.07- 0.60], p=0.004), but combined AD were more frequently observed (OR 4.71; CI [1.43-15.58], p=0.012). Most patients with severe AA were children (8/12) with polyvalent sensitization and respiratory and combined AD.
CONCLUSIONS: The comorbidity of AA and atopy is manifested by an increased incidence of severe alopecia in childhood and a tendency to progression of allergic inflammation, realized in the form of combined AD. The spectrum of sensitization in patients with and without AA does not differ and characterized by the predominance of the most common allergens (plant pollen). These results indicate the need for timely atopy detection and desensitization therapy in AA-patients, especially with early onset and active disease.
背景:临床、流行病学、遗传学和免疫学研究证实,斑秃(AA)与特应性疾病(AD)有关。对 AA 患者的致敏性和 AD 结构进行研究,有助于开展特应性筛查,并为 AA 提出更多的治疗方案。目的:考虑到脱发的年龄和临床形式,确定 AA 患者的致敏谱和 AD 结构。材料与方法:进行了一项非对照比较研究。研究使用了 162 名 5 - 51 岁 AA、特应性皮炎、哮喘、过敏性鼻炎/鼻神经炎患者在 2022 年 4 月至 2023 年 5 月期间的数据。对过敏的性质和过敏性鼻炎的结构进行了分析。通过脱发面积评估 AA 的临床形式。结果:根据 AA 状态对患者进行了划分:第一组包括 54 名患有 AD 的 AA 患者,第二组(对比组)--108 名没有 AA 的特应性患者。根据年龄进行分组:第一组--31(57%)名儿童(5 - 17 岁),23(43%)名 18 岁及以上成人;第二组--儿童和成人分别为 58(54%)和 50(46%)名。在 AA 患者中,季节性花粉过敏占多数(22/54 人);在 13/54 人中观察到多价过敏,其中 6 人患有严重的 AA,6 人患有虹膜炎。比较各组之间的致敏谱发现没有差异。在成年 AA 患者组中,孤立的呼吸道过敏明显较少(OR 0.21;CI [0.07-0.60],P=0.004),但合并的 AD 更常见(OR 4.71;CI [1.43-15.58],P=0.012)。大多数严重 AA 患者是儿童(8/12),他们具有多价致敏、呼吸道和合并 AD。结论:AA和特应性过敏的并发症表现为儿童期严重脱发的发病率增加以及过敏性炎症恶化的趋势,并以合并 AD 的形式表现出来。AA 患者和非 AA 患者的致敏谱并无差异,其特点是最常见的过敏原(植物花粉)占主导地位。这些结果表明,有必要对 AA 患者,尤其是早期发病和病情活跃的患者,及时进行特应性检测和脱敏治疗。